Compare NVAX & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | WLFC |
|---|---|---|
| Founded | 1987 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 1996 | 1997 |
| Metric | NVAX | WLFC |
|---|---|---|
| Price | $7.93 | $189.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $11.33 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 4.2M | 134.9K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | ★ 309.76 | 146.23 |
| EPS | N/A | ★ 3.26 |
| Revenue | ★ $1,123,479,000.00 | $569,223,000.00 |
| Revenue This Year | N/A | $2.75 |
| Revenue Next Year | N/A | $7.35 |
| P/E Ratio | ★ N/A | $58.56 |
| Revenue Growth | ★ 64.69 | 36.00 |
| 52 Week Low | $6.20 | $114.01 |
| 52 Week High | $11.85 | $244.62 |
| Indicator | NVAX | WLFC |
|---|---|---|
| Relative Strength Index (RSI) | 32.66 | 36.11 |
| Support Level | $7.78 | $165.65 |
| Resistance Level | $10.10 | $206.77 |
| Average True Range (ATR) | 0.42 | 10.55 |
| MACD | -0.14 | -5.14 |
| Stochastic Oscillator | 3.52 | 0.00 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum Lease rent revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.